Evidence map›Paper›PMID 36540148›Full record

ArticleNeurology. Clinical practice2022

Single-Center Description of Therapeutic Anticoagulation Practices and Outcomes in Large Hemispheric Infarctions.

Hannah Breit, Andrea Sterenstein, Nandini Abburi, Sarah Song, Sayona John, Ivan Da Silva, Lauren Koffman

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hannah BreitSection of Neurocritical Care (HB, AS, SS, SJ, IDS), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (NA), University of Washington, Seattle; and Department of Neurology (LK), Temple Health, Philadelphia, PA.
Andrea SterensteinSection of Neurocritical Care (HB, AS, SS, SJ, IDS), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (NA), University of Washington, Seattle; and Department of Neurology (LK), Temple Health, Philadelphia, PA.
Nandini AbburiSection of Neurocritical Care (HB, AS, SS, SJ, IDS), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (NA), University of Washington, Seattle; and Department of Neurology (LK), Temple Health, Philadelphia, PA.
Sarah SongSection of Neurocritical Care (HB, AS, SS, SJ, IDS), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (NA), University of Washington, Seattle; and Department of Neurology (LK), Temple Health, Philadelphia, PA.
Sayona JohnSection of Neurocritical Care (HB, AS, SS, SJ, IDS), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (NA), University of Washington, Seattle; and Department of Neurology (LK), Temple Health, Philadelphia, PA.
Ivan Da SilvaSection of Neurocritical Care (HB, AS, SS, SJ, IDS), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (NA), University of Washington, Seattle; and Department of Neurology (LK), Temple Health, Philadelphia, PA.
Lauren KoffmanSection of Neurocritical Care (HB, AS, SS, SJ, IDS), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (NA), University of Washington, Seattle; and Department of Neurology (LK), Temple Health, Philadelphia, PA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Large hemispheric infarctions (LHIs) are associated with significant morbidity and mortality, with limited data on therapeutic anticoagulation (AC) management. We provide a descriptive analysis of the type of therapeutic AC used, the timing of introduction, rate of of radiographic vs symptomatic hemorrhagic transformation (HT), and patient outcomes. Methods: This was a retrospective review of patients with acute ischemic stroke admitted to the Neurosciences intensive care unit at a tertiary care center from January 2012 to December 2018. Inclusion criteria included admission imaging with stroke size ≥ two-thirds of the middle cerebral artery territory, ± other vascular territory, and need for therapeutic AC. HT categories included hemorrhagic infarction types 1 and 2 and parenchymal hematoma types 1 and 2. The primary outcome included HT with and without an associated clinical change. Secondary outcomes included disposition at discharge and modified Rankin Scale (mRS) score at discharge and at follow-up when available. Results: A total of 2,317 patients were screened, 380 met the inclusion criteria for LHI, and 105 received AC. The mean age was 64 years (SD 16.8), and 50% (n = 53) were female. The mean admission NIH Stroke Scale score was 20 (SD 5.9). The mean poststroke timing to initiation of AC was 17 days (SD 10.1) (median 14 [interquartile range 10-19 days]). Indications for AC included atrial fibrillation (51%), cardiac thrombus (19%), venous thromboembolism (19%), and other (10%). Heparin was most commonly used in the very early (≤7 days) group (n = 11, 79%), whereas vitamin K antagonists without a bridge were the most commonly used among the entire cohort (n = 54, 51%). Radiographic HT was seen in 68 patients (65%) before AC initiation. After initiation of AC, 70 patients had repeat imaging, with 6 cases (6%) of worsening radiographic HT and 4 cases (4%) of symptomatic deterioration, of which 3 required reversal of AC. At discharge, 7 patients (7%) had a good outcome (mRS score 0-2). Discussion: Although radiographic HT is common among patients with LHI, it does not always portend symptomatic clinical deterioration. Further research regarding AC timing and safety is necessary.

Identifiers

PMID36540148
PMCPMC9757115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.